2010년 전국 72개 병원에서 신생아 호흡곤란증후군의 폐 표면활 성제 치료 결과: 지난 20년간의 비교
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 배종우 | - |
dc.contributor.author | 한원호 | - |
dc.contributor.author | 장지영 | - |
dc.contributor.author | 김성미 | - |
dc.date.accessioned | 2021-08-12T06:26:36Z | - |
dc.date.available | 2021-08-12T06:26:36Z | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 2287-9412 | - |
dc.identifier.issn | 2287-9803 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/17032 | - |
dc.description.abstract | In Korea, pulmonary surfactant (PS) replacement therapy in respiratory distress syndrome (RDS) was started in 1991 since when Surfacten^® was imported from Japan. At the present time, Surfacten^®, Newfactan^®, Curosurf^®, and Infasurf^® are available in Korea. The governmental health insurance covers the expense for multiple dose treatment since 2002 and the early prophylactic treatment (BW: <1,250 g or GP: <30 wks) since 2011. We undertook a multi-institutional collective study to evaluate the outcomes of PS over past 20 years in Korea (Period-I; 1990/91, P-II; 1996, P-III; 2002, and P-IV; 2007, P-V; 2010). There were 60 RDS neonates with PS treatment in P-I (16 hospitals), 1,179 in P-II (64), 1,595 in P-III (62), 1,921 in P-IV (57), and 3,160 in P-V (72). Decreased mortality rate, defined as the percentage of neonates who died within 28 days of birth, was seen between periods, P-V vs P-I, II, III,and IV (mortality rate: 10.1% vs. 40.0%, 30.0%, 18.7%, and 14.3%). We conclude that PS therapy contributed to improve remarkable outcome in RDS neonates over the last 20 years in Korea. However, more efforts should be made to optimize PS therapy for better outcome. Multiple PS doses for relapse and poor response, early prophylactic use, and better supportive care for pre-term infants are mandatory. | - |
dc.format.extent | 3 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한신생아학회 | - |
dc.title | 2010년 전국 72개 병원에서 신생아 호흡곤란증후군의 폐 표면활 성제 치료 결과: 지난 20년간의 비교 | - |
dc.title.alternative | Surfactant Replacement Therapy for RDS: a Collaborative Study of 72 Multi-center Trials in Korea (2010) and a Review of Korean Experiences over 20 Years | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.bibliographicCitation | Neonatal medicine, v.18, no.2, pp 409 - 411 | - |
dc.citation.title | Neonatal medicine | - |
dc.citation.volume | 18 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 409 | - |
dc.citation.endPage | 411 | - |
dc.identifier.kciid | ART001608177 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kciCandi | - |
dc.subject.keywordAuthor | Respiratory distress syndrome | - |
dc.subject.keywordAuthor | Newborn | - |
dc.subject.keywordAuthor | Premature | - |
dc.subject.keywordAuthor | Complications | - |
dc.subject.keywordAuthor | Epidemiology mortality pulmonary surfactant | - |
dc.subject.keywordAuthor | Analysis therapeutic use data collection | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.